Ratios of neutrophils to lymphocytes and platelets to lymphocytes in ankylosing spondylitis with disease activity relationship

Shahla Taha  Ahmad; Shwan Kader  Media

doi:10.56056/amj.2024.293

Authors

Shahla Taha Ahmad MBChB, Student Trainee of Kurdistan Higher Council of Medical Specialties, Department of Rheumatology, Rizgary Teaching Hospital, Erbil -Iraq
Shwan Kader Media PhD, Assistant professor in rheumatology and medical rehabilitation/HMU. Program director of KHCMs rheumatology, Rizgary Teaching Hospital, Erbil -Iraq.

DOI:

https://doi.org/10.56056/amj.2024.293

Keywords:

Ankylosing spondylitis, Neutrophile to lymphocyte ratio, Platelet to lymphocyte ratio

Abstract

Background and objectives: Ankylosing spondylitis impacts the fibers and synovial tissues of the sacroiliac and spinal joint and is most noticeable commencement occurs in males. This study aimed to evaluate the correlation between ratios of neutrophils to lymphocytes and platelets to lymphocytes in patients with ankylosing spondylitis.

Methods: This was a case control study performed at Rheumatology units of Erbil and Rizgari teaching hospitals between January 2022 and March 2023. Inclusion criteria involved patients with ankylosing spondylitis based on the criteria developed by Bath Ankylosing Spondylitis Disease Activity Index score. Neutrophil / lymphocyte and platelet / lymphocyte ratio has been calculated manually from the laboratory results.

Results: Disease activity evaluated based on Bath Ankylosing Spondylitis Disease Activity Index Score. Patients with active disease had higher Neutrophil / lymphocyte ratio than inactive and control group with a value of 2.27 ± 0.34, 2.03 ± 0.58, and 1.92 ± 0.93 for the three groups respectively; this difference was statistically significant. The same correlation was found in terms of platelet to lymphocyte ratio with values of 149.92 ± 31.13 for active group and 126.88± 58.38 and 129.74 ± 63.16 for inactive and control group respectively. There was a weak negative and not significant correlation between both Neutrophil / lymphocyte and platelet / lymphocyte ratio and Bath Ankylosing Spondylitis Disease Activity Index Score.

Conclusion: Potential indicators of the activity of ankylosing spondylitis include the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio.

Downloads

Download data is not yet available.

References

Song Z-Y, Yuan D, Zhang S-X. Role of the microbiome and its metabolites in ankylosing spondylitis. Front Immunol. 2022; 13:1010572.

Dakwar E, Reddy J, Vale FL, Uribe JS. A review of the pathogenesis of ankylosing spondylitis. Neurosurg Focus. 2008; 24:2-9.

Curtis JR, Winthrop K, Bohn RL, Suruki R, Siegel S, Stark JL, et al. The annual diagnostic prevalence of ankylosing spondylitis and axial spondyloarthritis in the United States using Medicare and MarketScan databases. ACR Open Rheumatol. 2021; 3:743–52.

Braun A, Saracbasi E, Grifka J, Schnitker J, Braun J. Identifying patients with axial spondyloarthritis in primary care: How useful are items indicative of inflammatory back pain Ann Rheum Dis. Ann Rheum Dis. 2011; 70:1782–7.

Kjeken I, Dagfinrud H, Slatkowsky-Christensen B, Mowinckel P, Uhlig T, Kvien TK, et al. Activity limitations and participation restrictions in women with hand osteoarthritis: patients’ descriptions and associations between dimensions of functioning. Ann Rheum Dis. 2005; 64:1633–8.

Choi EY, Lee M, Lee CS, Choi EY, Lee M, Lee CEY. Uveitis occurrence in patients with ankylosing spondylitis according to the type of tumour necrosis factor inhibitor: a cohort study of 175 patients Uveitis during anti-TNF therapy for AS / E. Clin Exp Rheumatol. 2020; 38:102–13.

Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006; 54:569–78.

Van Tubergen A, Weber U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol. 2012; 8:253–61.

Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis - Insights into pathogenesis. Nat Rev Rheumatol. 2016; 12:81–91.

Han R, Xia Q, Xu S, Fan D, Pan F. Interleukin-23 receptor polymorphism (rs10889677 A/C) in ankylosing spondylitis: Meta-analysis in Caucasian and Asian populations. Clin Chim Acta. 2018; 477:53–9.

Zhao S, Duffield SJ, Moots RJ, Goodson NJ. Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. Rheumatology (Oxford). 2014; 53:1595–603.

Kobelt G. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade(R)). Rheumatology. 2004; 43:1158–66.

Azab B, Daoud J, Naeem FB, Nasr R, Ross J, Ghimire P, et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail. 2012; 34:571–6.

Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34:326–34.

Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020; 18:360.

Kurtul A, Ornek E. Platelet to lymphocyte ratio in cardiovascular diseases: A systematic review. Angiology. 2019; 70:802–18.

Co?kun BN, Öksüz MF, Ermurat S, Tufan AN, Oruço?lu N, Do?an A, et al. Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis. Eur J Rheumatol. 2014; 1:101–5.

Gökmen F, Akbal A, Re?orlu H. Neutrophil- lymphocyte ratio connected to treatment options and inflammation markers of Ankylosing spondylitis. J Clin Lab Anal. 2015; 29:294–8.

Boyraz I, Onur Caglar S, Erdem F, Yazici M, Yazici S, Koc B, et al. Assessment of relation between neutrophil lympocyte, platelet lympocyte ratios and epicardial fat thickness in patients with ankylosing spondylitis. Med Glas (Zenica). 2016; 13:14–7.

Mercan R, Bitik B, Tufan A. The association between neutrophil/ lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. 2016; 30:597–601.

Boyraz ?, Koç B. Ratio of neutrophil/lymphocyte and platelet/ lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. Int J Clin Exp Med. 2014; 7:2912–5.

Öz ?ahin M, Demirin H, Uçgun T. Neutrophil-lymphocyte ratio in patients with ankylosing spondylitis. Abant Med J. 2014; 3:16–20.

Bozan N, Alpayc? M, Aslan M, Cankaya H, K?roglu AF, Turan M, et al. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds. Eur Arch Otorhinolaryngol. 2016; 273:3663–72.

Kucuk A, Uslu AU, Ugan Y, Bagcaci S, Karahan AY, Akarmut A, et al. Neutrophil-to-lymphocyte ratio is involved in the severity of ankylosing spondylitis. Bratisl Lek Listy. 2015; 116:722–5.

Inal EE, Sunar I. May neutrophil- lymphocyte and platelet lymphocyte ratios indicate disease activity in ankylosing spondylitis Arch Rheumatol. 2015; 30:130–7.

Scilla KA, Bentzen SM, Lam VK, Mohindra P, Nichols EM, Vyfhuis MA, et al. Neutrophil-lymphocyte ratio is a prognostic marker in patients with locally advanced (stage IIIA and IIIB) non-small cell lung cancer treated with combined modality therapy. Oncologist. 2017; 22:737–42.

Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021; 122:474–88.

Xie T, Hou D, Wang J, Zhao S. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma. Front Pediatr. 2023; 11:904730.